APO Research
Talk to an analyst

APO RESEARCH · REPORT

Proto Oncogene Tyrosine Protein Kinase Src

Compare research editions
View pricing & licenses

Selected research

Industry Research

Proto Oncogene Tyrosine Protein Kinase Src Industry Research Report 2026

1 January 2026123 pages

Choose your research edition.

Industry ResearchProto Oncogene Tyrosine Protein Kinase Src Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Proto Oncogene Tyrosine Protein Kinase Src Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Proto Oncogene Tyrosine Protein Kinase Src Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Proto Oncogene Tyrosine Protein Kinase Src Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Proto Oncogene Tyrosine Protein Kinase Src Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Proto Oncogene Tyrosine Protein Kinase Src market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Proto Oncogene Tyrosine Protein Kinase Src is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Proto Oncogene Tyrosine Protein Kinase Src is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Proto Oncogene Tyrosine Protein Kinase Src is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Proto Oncogene Tyrosine Protein Kinase Src include Avalyn Pharma Inc, KeifeRx LLC, Lead Discovery Center GmbH, TopiVert Ltd, Turning Point Therapeutics Inc, AstraZeneca Plc, AbbVie Inc, Boehringer Ingelheim International GmbH and Taiwan Liposome Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Proto Oncogene Tyrosine Protein Kinase Src market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Proto Oncogene Tyrosine Protein Kinase Src Market by Company

Avalyn Pharma Inc

KeifeRx LLC

Lead Discovery Center GmbH

TopiVert Ltd

Turning Point Therapeutics Inc

AstraZeneca Plc

AbbVie Inc

Boehringer Ingelheim International GmbH

Taiwan Liposome Co Ltd

Proto Oncogene Tyrosine Protein Kinase Src Segment by Type

Proto Oncogene c Src

SRC

Pp60c src

EC 2.7.10.2

Proto Oncogene Tyrosine Protein Kinase Src Segment by Application

Infectious Disease

Respiratory

Musculoskeletal Disorders

Gastrointestinal

Ophthalmology

Genetic Disorders

Central Nervous System

Oncology

Proto Oncogene Tyrosine Protein Kinase Src Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Proto Oncogene Tyrosine Protein Kinase Src market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Proto Oncogene Tyrosine Protein Kinase Src and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Proto Oncogene Tyrosine Protein Kinase Src.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Proto Oncogene Tyrosine Protein Kinase Src manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Proto Oncogene Tyrosine Protein Kinase Src by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Proto Oncogene Tyrosine Protein Kinase Src in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Proto Oncogene Tyrosine Protein Kinase Src Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Manufacturers (2021-2026) Table 8. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue of Manufacturers (2021-2026) Table 9. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Proto Oncogene Tyrosine Protein Kinase Src Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Proto Oncogene Tyrosine Protein Kinase Src Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Proto Oncogene Tyrosine Protein Kinase Src, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Proto Oncogene Tyrosine Protein Kinase Src, Product Type & Application Table 14. Global Proto Oncogene Tyrosine Protein Kinase Src Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Proto Oncogene Tyrosine Protein Kinase Src by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Avalyn Pharma Inc Company Information Table 19. Avalyn Pharma Inc Business Overview Table 20. Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 22. Avalyn Pharma Inc Recent Developments Table 23. KeifeRx LLC Company Information Table 24. KeifeRx LLC Business Overview Table 25. KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 27. KeifeRx LLC Recent Developments Table 28. Lead Discovery Center GmbH Company Information Table 29. Lead Discovery Center GmbH Business Overview Table 30. Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 32. Lead Discovery Center GmbH Recent Developments Table 33. TopiVert Ltd Company Information Table 34. TopiVert Ltd Business Overview Table 35. TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 37. TopiVert Ltd Recent Developments Table 38. Turning Point Therapeutics Inc Company Information Table 39. Turning Point Therapeutics Inc Business Overview Table 40. Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 42. Turning Point Therapeutics Inc Recent Developments Table 43. AstraZeneca Plc Company Information Table 44. AstraZeneca Plc Business Overview Table 45. AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 47. AstraZeneca Plc Recent Developments Table 48. AbbVie Inc Company Information Table 49. AbbVie Inc Business Overview Table 50. AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 52. AbbVie Inc Recent Developments Table 53. Boehringer Ingelheim International GmbH Company Information Table 54. Boehringer Ingelheim International GmbH Business Overview Table 55. Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 57. Boehringer Ingelheim International GmbH Recent Developments Table 58. Taiwan Liposome Co Ltd Company Information Table 59. Taiwan Liposome Co Ltd Business Overview Table 60. Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 62. Taiwan Liposome Co Ltd Recent Developments Table 63. Global Proto Oncogene Tyrosine Protein Kinase Src Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 64. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2021-2026) & (K Units) Table 65. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Region (2021-2026) Table 66. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2027-2032) & (K Units) Table 67. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Region (2027-2032) Table 68. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Region (2021-2026) Table 70. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2027-2032) & (US$ Million) Table 71. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Region (2027-2032) Table 72. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2026) & (K Units) Table 74. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2027-2032) & (K Units) Table 75. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2027-2032) & (US$ Million) Table 77. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2026) & (K Units) Table 79. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2027-2032) & (K Units) Table 80. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2027-2032) & (US$ Million) Table 82. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2026) & (K Units) Table 84. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2027-2032) & (K Units) Table 85. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2026) & (US$ Million) Table 86. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2027-2032) & (US$ Million) Table 87. South America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2026) & (K Units) Table 89. South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2027-2032) & (K Units) Table 90. South America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2026) & (US$ Million) Table 91. South America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2027-2032) & (US$ Million) Table 92. Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2026) & (K Units) Table 94. Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2027-2032) & (K Units) Table 95. Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2026) & (US$ Million) Table 96. Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2027-2032) & (US$ Million) Table 97. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2021-2026) & (K Units) Table 98. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2027-2032) & (K Units) Table 99. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2021-2026) Table 100. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2027-2032) Table 101. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2021-2026) & (US$ Million) Table 102. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2027-2032) & (US$ Million) Table 103. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2021-2026) Table 104. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2027-2032) Table 105. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Type (2021-2026) & (US$/Unit) Table 106. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Type (2027-2032) & (US$/Unit) Table 107. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2021-2026) & (K Units) Table 108. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2027-2032) & (K Units) Table 109. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2021-2026) Table 110. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2027-2032) Table 111. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2021-2026) & (US$ Million) Table 112. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2027-2032) & (US$ Million) Table 113. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2021-2026) Table 114. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2027-2032) Table 115. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Application (2021-2026) & (US$/Unit) Table 116. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Application (2027-2032) & (US$/Unit) Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Proto Oncogene Tyrosine Protein Kinase Src Distributors List Table 120. Proto Oncogene Tyrosine Protein Kinase Src Customers List Table 121. Proto Oncogene Tyrosine Protein Kinase Src Industry Trends Table 122. Proto Oncogene Tyrosine Protein Kinase Src Industry Drivers Table 123. Proto Oncogene Tyrosine Protein Kinase Src Industry Restraints Table 124. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Proto Oncogene Tyrosine Protein Kinase Src Product Image Figure 5. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Proto Oncogene Tyrosine Protein Kinase Src Market Size (2021-2032) & (US$ Million) Figure 7. Global Proto Oncogene Tyrosine Protein Kinase Src Sales (2021-2032) & (K Units) Figure 8. Global Proto Oncogene Tyrosine Protein Kinase Src Average Price (US$/Unit) & (2021-2032) Figure 9. Proto Oncogene c Src Product Image Figure 10. SRC Product Image Figure 11. Pp60c src Product Image Figure 12. EC 2.7.10.2 Product Image Figure 13. Infectious Disease Product Image Figure 14. Respiratory Product Image Figure 15. Musculoskeletal Disorders Product Image Figure 16. Gastrointestinal Product Image Figure 17. Ophthalmology Product Image Figure 18. Genetic Disorders Product Image Figure 19. Central Nervous System Product Image Figure 20. Oncology Product Image Figure 21. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Manufacturers in 2025 Figure 22. Global Manufacturers of Proto Oncogene Tyrosine Protein Kinase Src, Manufacturing Sites & Headquarters Figure 23. Global Top 5 and 10 Proto Oncogene Tyrosine Protein Kinase Src Players Market Share by Revenue in 2025 Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Proto Oncogene Tyrosine Protein Kinase Src Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 26. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region in 2025 Figure 27. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region in 2025 Figure 28. North America Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country in 2025 Figure 29. North America Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2021-2032) Figure 30. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Country (2021-2032) Figure 31. United States Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Canada Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country in 2025 Figure 34. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2021-2032) Figure 35. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Country (2021-2032) Figure 36. Germany Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country in 2025 Figure 42. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Country (2021-2032) Figure 44. China Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. China Taiwan Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country in 2025 Figure 53. South America Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2021-2032) Figure 54. South America Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Country (2021-2032) Figure 55. Mexico Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Brazil Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country in 2025 Figure 59. Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Country (2021-2032) Figure 61. Turkey Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. UAE Proto Oncogene Tyrosine Protein Kinase Src Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2021-2032) Figure 65. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2021-2032) Figure 66. Global Proto Oncogene Tyrosine Protein Kinase Src Price (US$/Unit) by Type (2021-2032) Figure 67. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2021-2032) Figure 68. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2021-2032) Figure 69. Global Proto Oncogene Tyrosine Protein Kinase Src Price (US$/Unit) by Application (2021-2032) Figure 70. Proto Oncogene Tyrosine Protein Kinase Src Value Chain Figure 71. Proto Oncogene Tyrosine Protein Kinase Src Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Proto Oncogene Tyrosine Protein Kinase Src Industry Opportunities and Challenges

Scope & coverage.

Types
  • Proto Oncogene c Src
  • SRC
  • Pp60c src
  • EC 2.7.10.2
Applications
  • Infectious Disease
  • Respiratory
  • Musculoskeletal Disorders
  • Gastrointestinal
  • Ophthalmology
  • Genetic Disorders
  • Central Nervous System
  • Oncology
Companies covered
  • Avalyn Pharma Inc
  • KeifeRx LLC
  • Lead Discovery Center GmbH
  • TopiVert Ltd
  • Turning Point Therapeutics Inc
  • AstraZeneca Plc
  • AbbVie Inc
  • Boehringer Ingelheim International GmbH
  • Taiwan Liposome Co Ltd

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Market Size (2021-2032)
  4. 2.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales (2021-2032)
  5. 2.2.3 Global Proto Oncogene Tyrosine Protein Kinase Src Market Average Price (2021-2032)
  6. 2.3 Proto Oncogene Tyrosine Protein Kinase Src by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Proto Oncogene c Src
  9. 2.3.3 SRC
  10. 2.3.4 Pp60c src
  11. 2.3.5 EC 2.7.10.2
  12. 2.4 Proto Oncogene Tyrosine Protein Kinase Src by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Infectious Disease
  15. 2.4.3 Respiratory
  16. 2.4.4 Musculoskeletal Disorders
  17. 2.4.5 Gastrointestinal
  18. 2.4.6 Ophthalmology
  19. 2.4.7 Genetic Disorders
  20. 2.4.8 Central Nervous System
  21. 2.4.9 Oncology
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Proto Oncogene Tyrosine Protein Kinase Src Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Proto Oncogene Tyrosine Protein Kinase Src Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Proto Oncogene Tyrosine Protein Kinase Src Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Proto Oncogene Tyrosine Protein Kinase Src, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Proto Oncogene Tyrosine Protein Kinase Src, Product Type & Application
  8. 3.8 Global Manufacturers of Proto Oncogene Tyrosine Protein Kinase Src, Established Date
  9. 3.9 Global Proto Oncogene Tyrosine Protein Kinase Src Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Avalyn Pharma Inc
  2. 4.1.1 Avalyn Pharma Inc Company Information
  3. 4.1.2 Avalyn Pharma Inc Business Overview
  4. 4.1.3 Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  6. 4.1.5 Avalyn Pharma Inc Recent Developments
  7. 4.2 KeifeRx LLC
  8. 4.2.1 KeifeRx LLC Company Information
  9. 4.2.2 KeifeRx LLC Business Overview
  10. 4.2.3 KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  12. 4.2.5 KeifeRx LLC Recent Developments
  13. 4.3 Lead Discovery Center GmbH
  14. 4.3.1 Lead Discovery Center GmbH Company Information
  15. 4.3.2 Lead Discovery Center GmbH Business Overview
  16. 4.3.3 Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  18. 4.3.5 Lead Discovery Center GmbH Recent Developments
  19. 4.4 TopiVert Ltd
  20. 4.4.1 TopiVert Ltd Company Information
  21. 4.4.2 TopiVert Ltd Business Overview
  22. 4.4.3 TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  24. 4.4.5 TopiVert Ltd Recent Developments
  25. 4.5 Turning Point Therapeutics Inc
  26. 4.5.1 Turning Point Therapeutics Inc Company Information
  27. 4.5.2 Turning Point Therapeutics Inc Business Overview
  28. 4.5.3 Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  30. 4.5.5 Turning Point Therapeutics Inc Recent Developments
  31. 4.6 AstraZeneca Plc
  32. 4.6.1 AstraZeneca Plc Company Information
  33. 4.6.2 AstraZeneca Plc Business Overview
  34. 4.6.3 AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  36. 4.6.5 AstraZeneca Plc Recent Developments
  37. 4.7 AbbVie Inc
  38. 4.7.1 AbbVie Inc Company Information
  39. 4.7.2 AbbVie Inc Business Overview
  40. 4.7.3 AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  42. 4.7.5 AbbVie Inc Recent Developments
  43. 4.8 Boehringer Ingelheim International GmbH
  44. 4.8.1 Boehringer Ingelheim International GmbH Company Information
  45. 4.8.2 Boehringer Ingelheim International GmbH Business Overview
  46. 4.8.3 Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  48. 4.8.5 Boehringer Ingelheim International GmbH Recent Developments
  49. 4.9 Taiwan Liposome Co Ltd
  50. 4.9.1 Taiwan Liposome Co Ltd Company Information
  51. 4.9.2 Taiwan Liposome Co Ltd Business Overview
  52. 4.9.3 Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  54. 4.9.5 Taiwan Liposome Co Ltd Recent Developments
5 Global Proto Oncogene Tyrosine Protein Kinase Src Market Scenario by Region
  1. 5.1 Global Proto Oncogene Tyrosine Protein Kinase Src Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region: 2021-2032
  3. 5.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region: 2021-2026
  4. 5.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region: 2027-2032
  5. 5.3 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region: 2021-2032
  6. 5.3.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region: 2021-2026
  7. 5.3.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region: 2027-2032
  8. 5.4 North America Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
  9. 5.4.1 North America Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2032)
  11. 5.4.3 North America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
  15. 5.5.1 Europe Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2032)
  17. 5.5.3 Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
  35. 5.7.1 South America Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2032)
  37. 5.7.3 South America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2021-2032)
  2. 6.1.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2021-2032)
  4. 6.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2021-2032)
  5. 6.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Proto Oncogene Tyrosine Protein Kinase Src Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2021-2032)
  2. 7.1.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2021-2032)
  4. 7.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2021-2032)
  5. 7.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Proto Oncogene Tyrosine Protein Kinase Src Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Proto Oncogene Tyrosine Protein Kinase Src Value Chain Analysis
  2. 8.1.1 Proto Oncogene Tyrosine Protein Kinase Src Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Proto Oncogene Tyrosine Protein Kinase Src Production Mode & Process
  5. 8.2 Proto Oncogene Tyrosine Protein Kinase Src Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Proto Oncogene Tyrosine Protein Kinase Src Distributors
  8. 8.2.3 Proto Oncogene Tyrosine Protein Kinase Src Customers
9 Global Proto Oncogene Tyrosine Protein Kinase Src Analyzing Market Dynamics
  1. 9.1 Proto Oncogene Tyrosine Protein Kinase Src Industry Trends
  2. 9.2 Proto Oncogene Tyrosine Protein Kinase Src Industry Drivers
  3. 9.3 Proto Oncogene Tyrosine Protein Kinase Src Industry Opportunities and Challenges
  4. 9.4 Proto Oncogene Tyrosine Protein Kinase Src Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst